These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3033388)

  • 1. Reversing glomerular hypertension stabilizes established glomerular injury.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    Kidney Int; 1987 Mar; 31(3):752-9. PubMed ID: 3033388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S; Meyer TW; Rennke HG; Brenner BM
    J Clin Invest; 1985 Aug; 76(2):612-9. PubMed ID: 2993362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S239-41. PubMed ID: 3033177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    Am J Med; 1985 Sep; 79(3C):31-6. PubMed ID: 2996344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids amplify glomerular injury in rats with renal ablation.
    García DL; Rennke HG; Brenner BM; Anderson S
    Am J Hypertens; 1988 Jan; 1(1):54-7. PubMed ID: 3370134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
    Zatz R; Dunn BR; Meyer TW; Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1925-30. PubMed ID: 3011862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy.
    Dworkin LD; Feiner HD; Randazzo J
    Kidney Int; 1987 Mar; 31(3):718-24. PubMed ID: 3573536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.
    Garcia DL; Rennke HG; Brenner BM; Anderson S
    J Clin Invest; 1987 Sep; 80(3):867-74. PubMed ID: 3040810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP; Raij L
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
    Lafayette RA; Mayer G; Park SK; Meyer TW
    J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension.
    Dworkin LD; Tolbert E; Recht PA; Hersch JC; Feiner H; Levin RI
    Hypertension; 1996 Feb; 27(2):245-50. PubMed ID: 8567047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.
    Anderson S; Diamond JR; Karnovsky MJ; Brenner BM
    J Clin Invest; 1988 Nov; 82(5):1757-68. PubMed ID: 2846658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD; Benstein JA; Parker M; Tolbert E; Feiner HD
    Kidney Int; 1993 Apr; 43(4):808-14. PubMed ID: 8479116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease.
    Dworkin LD; Benstein JA; Tolbert E; Feiner HD
    J Am Soc Nephrol; 1996 Mar; 7(3):437-42. PubMed ID: 8704110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
    Wang JL; Cheng HF; Shappell S; Harris RC
    Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy.
    Neugarten J; Kaminetsky B; Feiner H; Schacht RG; Liu DT; Baldwin DS
    Kidney Int; 1985 Aug; 28(2):135-9. PubMed ID: 3834224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.